Pfizer alleged India has taken steps that call into question the sustainability of foreign investments and the ability to compete fairly.
The warning comes after two National Health Service (NHS) workers experienced 'anaphylactoid reaction' symptoms shortly after being injected, but are now said to be recovering well.
The UK's medicines regulator on Friday approved the Pfizer/BioNTech coronavirus vaccine for 12 to 15 year olds.
Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer , casting serious doubt on the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals group.
Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11 years, and they plan to seek regulatory approvals as soon as possible.
Though there is no official word, the sources said the government is not ready to give in to the indemnity demands of the US drug manufacturers against liabilities in case of adverse effects.
The United Kingdom on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus.
Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune.
On December 27 last year, Pfizer had moved to the US District Court for the District of Delaware against Dr Reddy's Laboratories Ltd and Dr Reddy's Laboratories Inc for infringement of Pfizer's crystalline atorvastatin patent.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
The next hearing on Pfizer's plea is slated for March 21
Pfizer Ltd, the Indian arm of the world's largest pharmaceutical company Pfizer Inc, is selling four consumer health brands that are household names in India Listerine, Benadryl, Caladryl and Benylin to Johnson & Johnson Ltd for Rs 214.85 crore, as part of J&J's acquisition of Pfizer's global consumer health business in June 2006.
Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.
This is the largest-ever purchase and donation of vaccines by a single country and a commitment by the American people to help protect people around the world from COVID-19, the White House said ahead of the announcement by Biden at the G-7 Summit in the UK.
rediffGURU Sushil Sukhwani offers expert advice about pursuing higher education abroad.
While Pfizer, the world's largest pharmaceutical company, is being criticised for its inability to come up with blockbuster drugs, its global research and development head said the company was working on one of its largest ever assemblage of drugs.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
Leading Indian drug firm Ranbaxy has launched court battles in Britain and the US against the American pharmaceutical giant Pfizer for the rights to produce the cholesterol drug atorvastatin at a cheaper price.
Pfizer had approached the court accusing Mumbai-based Ultratech India Ltd of adopting the name 'Fiagra', which was deceptively similar to its drug 'Vigara', to pass of its drug as that of the American company.\n\n\n\n
Dr Reddy's Laboratories Ltd filed a lawsuit seeking declaratory judgement against Pfizer in United States District Court for the District of New Jersey regarding its Abbreviated New Drug Application for Sertraline HCl.
In the international market, Pfizer completed its acquisition of Wyeth in 2009.
New York-based Pfizer now outsources about 15 per cent of its manufacturing capabilities. The company aims to double that figure, as part of cost-cutting measures.
Pharma major Pfizer on Tuesday launched Viagra, a drug developed for erectile dysfunction, in the Indian market. \n
Global pharmaceutical giant Pfizer on Wednesday said it planned to launch two to three products in India and a possible patented drug by 2007 in keeping with its target of a double digit growth in the country.
US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
The world's biggest drug maker Pfizer Inc has offered about Rs 680 crore to raise its stake in its Indian subsidiary to 75 per cent from 41 per cent. The offer of Rs 675 per share, however, is unlikely to find takers, since Pfizer share price rose 10.02 per cent to close at Rs 685.4 per share on the Bombay Stock Exchange (BSE) on Monday, analysts feel.
Pfizer, the world's largest pharmaceutical company, has filed patent infringement suits against Sun Pharma, Wockhardt Ltd and Lupin Ltd to prevent these companies from securing marketing approvals for the generic equivalents of its high-selling neuropathic pain management drug Lyrica in the United States.
Pfizer Ltd has said that its US parent company has nominated Kewal Handa as managing director of the company.
Interestingly, the allegations against Indian arm of the world's largest pharma maker also relates to its acquisition of the Indian subsidiary of Parke Davis by Pfizer in 2000.
Pharmaceutical major Pfizer and World Vision India on Thursday announced a grant of Rs 1 crore (Rs 10 million) under an economic rehabilitation programme for Tsunami affected communities, which WVI will extend as micro-finance development loans.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances